Allergan Inc. (AGN) Stock Research, Analysis & News

Quick Analysis on Allergan Inc. (AGN) Stock as of September 20, 2017

Previous Closing Price $215.00 is below its 50 day moving average $229.79
Previous Closing Price $215.00 is below its 200 day moving average $236.07
The Price/Earnings To Growth ratio (PEG) is great than 1
The Stock pays a dividend of 1.27%
The closing price $215.00 is more than 27.65% away from its one year target price of $274.44
Good Price to Book Ratio of 1.02
Current Short Ratio 3.43 is great than 1
(See more information about Allergan Inc. (AGN) Stock below)

Allergan Inc. (AGN) Stock Profile Summary

Allergan, Inc., a multi-specialty healthcare company, discovers, develops, and commercializes specialty pharmaceutical, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, obesity intervention, urological, and other specialty markets worldwide. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment offers a range of pharmaceutical products, including ophthalmic products for chronic dry eye, glaucoma therapy, ocular inflammation, infection, allergy, and retinal diseases; Botox for the therapeutic and aesthetic indications; skin care products for acne, psoriasis, and other skin care products; eyelash growth products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery; obesity intervention products, including the Lap-Band System and the Orbera Intragastric Balloon System; and facial aesthetics products. The company also offers Contigen for the treatment of urinary incontinence due to intrinsic sphincter deficiency. It sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, and ambulatory surgery centers, as well as to medical practitioners, including ophthalmologists, neurologists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, bariatric surgeons, pediatricians, urologists, and general practitioners. Allergan, Inc. has strategic research collaboration agreements with ExonHit Therapeutics S.A.; Spectrum Pharmaceuticals, Inc.; and Pieris AG. The company was founded in 1948 and is headquartered in Irvine, California.

Allergan Inc. (AGN) Stock Key Statistics Research and Analysis as of September 20, 2017

Stock ExchangeNYQ
Market Capitalization$70.22B
Trade Volume (Average Trading Volume)4,676,794 (2,047,050)
Current Year EPS Estimate$16.25
Next Year EPS Estimate$17.86
Previous Closing Price$215.00
50 Day Price Moving Average$229.79
200 Day Price Moving Average$236.07
Dividend Yield1.27%
1 yr Target Price$274.44
Ex-Dividend Date8/16/2017
PEG Ratio1.02
Short Ratio3.43

Allergan Inc. (AGN) Stock Competitor Research and Analysis

Alcon Inc. (ACL)Johnson & Johnson (JNJ)
Amgen Inc. (AMGN)Biogen Idec Inc. (BIIB)
Genzyme Corp. (GENZ)Gilead Sciences Inc. (GILD)
Life Technologies Corporation (LIFE)Teva Pharmaceutical Industries Limited (TEVA)
Watson Pharmaceuticals Inc. (WPI)King Pharmaceuticals Inc. (KG)
Mylan, Inc. (MYL)Pfizer Inc. (PFE)
GlaxoSmithKline plc (GSK)Sanofi-Aventis (SNY)
Novartis AG (NVS)AstraZeneca PLC (AZN)
Abbott Laboratories (ABT)

Mutual Funds with Allergan Inc. (AGN) Stock in its top 10 holdings

FundCategoryAGN Holding Percentage
Thrivent Large Cap Growth ALarge Growth4.34%
Alger Capital Appreciation ALarge Growth2.07%
Alger Capital Appreciation Instl RLarge Growth2.07%
Alger Green CLarge Growth2.25%
Alger Capital Appreciation Instl ILarge Growth2.07%

ETFs with Allergan Inc. (AGN) Stock in its top 10 holdings

Stock Research on Allergan Inc. (AGN)

Latest Market News on Allergan Inc. (AGN)

Click here to find the latest news on Allergan Inc. (AGN)

Looking for Market Opportunties?

Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center

See other companies in the same industry

Alcon Inc. (ACL)
Johnson & Johnson (JNJ)
Amgen Inc. (AMGN)
Biogen Idec Inc. (BIIB)
Genzyme Corp. (GENZ)
Gilead Sciences Inc. (GILD)
Life Technologies Corporation (LIFE)
Teva Pharmaceutical Industries Limited (TEVA)
Watson Pharmaceuticals Inc. (WPI)
King Pharmaceuticals Inc. (KG)
Mylan, Inc. (MYL)
Pfizer Inc. (PFE)
GlaxoSmithKline plc (GSK)
Sanofi-Aventis (SNY)
Novartis AG (NVS)
AstraZeneca PLC (AZN)
Abbott Laboratories (ABT)